(Q47805031)

English

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

author name string

Fangjun Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Innocent Mboudjeka

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Siyuan Shen

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Te-Hui W Chou

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Shixia Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Ted M Ross

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

22

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

13-14

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

1764-1772

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

DNA vaccines for viral infections: basic studies and applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Issues for improving multiplasmid DNA vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

C3d enhancement of neutralizing antibodies to measles hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Neutralization titres and vertical HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Maturation of the immune response in germinal centers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.09.054

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068860

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47805031&oldid=2171543529"